II. Indications
- See Linezolid
- Complicated Skin Infections including MRSA
III. Contraindications
- Not Approved for use in children
-
Neutropenia
- Tedizolid may be less effective in the absence of adequate Neutrophils
IV. Mechanism
- See Linezolid
- Oxazolidinone Antibiotic (same class as Linezolid)
- Ingested as prodrug Tedizolid phosphate and rapidly metabolized in vivo to active Tedizolid
V. Dosing: Adult
- Give 200 mg oral or IV infused over 1 hour once daily for 6 days
VIII. Safety
- Pregnancy Category C (unknown safety in humans)
- Unknown safety in Lactation
- Monitoring
- No Complete Blood Count monitoring required (unlike Linezolid)
IX. Drug Interactions
- See Linezolid
- No CYP450 interactions
-
MAO Inhibitor reaction risk (e.g. serotonergic or adrenergic interactions, tyramines)
- Tedizolid is a weak, reversible MAO Inhibitor
- Other possible interactions (consider holding these agents)
X. Resources
- Tedizolid Tablet (DailyMed)
XI. References
- (2014) Med Lett Drugs Ther 56(1449):73-5
Images: Related links to external sites (from Bing)
Related Studies
Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
MSH | C546016 |
LNC | LP172578-9, MTHU046340 |
English | 3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-5-hydroxymethyloxazolidin-2-one, torezolid, (5R)-3-(3-Fluoro-4-(6-(2-Methyl-2H-Tetrazol-5-yl)Pyridin-3-yl)Phenyl)-5-(Hydroxymethyl)Oxazolidin-2-One, 2-Oxazolidinone, 3-(3-Fluoro-4-(6-(2-Methyl-2H-Tetrazol-5-yl)-3-Pyridinyl)Phenyl)-5-(Hydroxymethyl)-, (5R)-, Tedizolid, Torezolid, TEDIZOLID |